SEC Form 4 · accession 0001193125-26-308137
MANNKIND CORP · MNKD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dominic Marasco
Officer — Pres, Endocrine Business Unit
Period of report
Jul 15, 2026
Accepted (ET)
Jul 17, 2026 · 9:47 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000899460
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par ValueF2 | Jul 15, 2026 | F | 3,623 | $4.09 | D | 343,398 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units.
- F2Includes 2,775 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2026.